Travere Therapeutics (TVTX) Net Income (2011 - 2026)

Travere Therapeutics' (TVTX) quarterly Net Income came in at -$500000.0 in Q1 2026, down 102.02% on a QoQ basis from $24.7 million in Q4 2025.

Travere Therapeutics (TVTX) Net Income (2011 - 2026) Analysis & Trends

Travere Therapeutics (TVTX) has 16 years of Net Income data on file, last reported at -$500000.0 in Q1 2026.

Quarterly Net Income changed N/A year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.2 million (up 3013.96% YoY) and the FY2025 annual result came in at $24.7 million, up 2801.09% from the prior year.
Net Income retreated to -$500000.0 in Q1 2026, from $24.7 million in the prior quarter.
In the past five years, Net Income ranged from a high of $240.0 million in Q3 2023 to a low of -$1.6 million in Q4 2023.
A 5-year average of $24.4 million and a median of $8.0 million in 2022 frame the typical range for Net Income.
Annual changes were most pronounced in 2023 — Net Income plunged 107.96% — and 2025, when it soared 164866.67%.
Tracing TVTX's Net Income over 5 years: stood at $19.8 million in 2022, then plunged by 107.96% to -$1.6 million in 2023, then jumped by 99.05% to -$15000.0 in 2024, then soared by 164866.67% to $24.7 million in 2025, then tumbled by 102.02% to -$500000.0 in 2026.
The last three Net Income figures came in at -$500000.0 (Q1 2026), $24.7 million (Q4 2025), and -$15000.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	1.10 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.30 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	482.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-644.37 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	237.01 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	930.12
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	81.49 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	164.49 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-13.27 Mn
10	Travere Therapeutics	5.85 Bn	5.85 Bn	162.52 Mn	-

Download Data